Cargando…

Increased DNA Dicarbonyl Glycation and Oxidation Markers in Patients with Type 2 Diabetes and Link to Diabetic Nephropathy

Aim. The aim of this study was to assess the changes of markers of DNA damage by glycation and oxidation in patients with type 2 diabetes and the association with diabetic nephropathy. Methodology. DNA oxidation and glycation adducts were analysed in plasma and urine by stable isotopic dilution anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waris, Sahar, Winklhofer-Roob, Brigitte M., Roob, Johannes M., Fuchs, Sebastian, Sourij, Harald, Rabbani, Naila, Thornalley, Paul J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408631/ https://www.ncbi.nlm.nih.gov/pubmed/25950009 http://dx.doi.org/10.1155/2015/915486

Ejemplares similares

Imidazopurinones are markers of physiological genomic damage linked to DNA instability and glyoxalase 1-associated tumour multidrug resistance
por: Thornalley, Paul J., et al.
Publicado: (2010)

Urinary Metabolomic Markers of Protein Glycation, Oxidation, and Nitration in Early-Stage Decline in Metabolic, Vascular, and Renal Health
por: Masania, Jinit, et al.
Publicado: (2019)

Dicarbonyl stress, protein glycation and the unfolded protein response
por: Rabbani, Naila, et al.
Publicado: (2021)

Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2010)

Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics
por: Rabbani, Naila, et al.
Publicado: (2016)

Serum Levels of Advanced Glycation Endproducts and Other Markers of Protein Damage in Early Diabetic Nephropathy in Type 1 Diabetes
por: Perkins, Bruce A., et al.
Publicado: (2012)

Urinary Collagen Fragments Are Significantly Altered in Diabetes: A Link to Pathophysiology
por: Maahs, David M., et al.
Publicado: (2010)

Dicarbonyl stress in clinical obesity
por: Masania, Jinit, et al.
Publicado: (2016)

An Introduction to the Special Issue “Protein Glycation in Food, Nutrition, Health and Disease”
por: Rabbani, Naila, et al.
Publicado: (2022)

Progesterone-associated arginine decline at luteal phase of menstrual cycle and associations with related amino acids and nuclear factor kB activation
por: Faustmann, Gernot, et al.
Publicado: (2018)

Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
por: Rabbani, Naila, et al.
Publicado: (2022)

Mass spectrometric determination of early and advanced glycation in biology
por: Rabbani, Naila, et al.
Publicado: (2016)

Protein glycation – biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
por: Rabbani, Naila, et al.
Publicado: (2021)

Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention
por: Brings, Sebastian, et al.
Publicado: (2017)

Hexokinase-2-Linked Glycolytic Overload and Unscheduled Glycolysis—Driver of Insulin Resistance and Development of Vascular Complications of Diabetes
por: Rabbani, Naila, et al.
Publicado: (2022)

Protein Glycation in Plants—An Under-Researched Field with Much Still to Discover
por: Rabbani, Naila, et al.
Publicado: (2020)

Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease
por: Rabbani, Naila, et al.
Publicado: (2022)

Glycation of LDL by Methylglyoxal Increases Arterial Atherogenicity: A Possible Contributor to Increased Risk of Cardiovascular Disease in Diabetes
por: Rabbani, Naila, et al.
Publicado: (2011)

Increased Glycation and Oxidative Damage to Apolipoprotein B100 of LDL Cholesterol in Patients With Type 2 Diabetes and Effect of Metformin
por: Rabbani, Naila, et al.
Publicado: (2010)

Advanced Glycation End Products in Extracellular Matrix Proteins Contribute to the Failure of Sensory Nerve Regeneration in Diabetes
por: Duran-Jimenez, Beatriz, et al.
Publicado: (2009)

High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
por: Perkins, Bruce A., et al.
Publicado: (2020)

Protein oxidation, nitration and glycation biomarkers for early-stage diagnosis of osteoarthritis of the knee and typing and progression of arthritic disease
por: Ahmed, Usman, et al.
Publicado: (2016)

Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress
por: Kurz, Alexander, et al.
Publicado: (2010)

Does aging affect the immune status? A comparative analysis in 300 healthy volunteers from France, Austria and Spain
por: Vasson, Marie-Paule, et al.
Publicado: (2013)

Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
por: Pusceddu, Irene, et al.
Publicado: (2019)

Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls
por: Fokkens, Bernardina T., et al.
Publicado: (2017)

Glycation marker glucosepane increases with the progression of osteoarthritis and correlates with morphological and functional changes of cartilage in vivo
por: Legrand, Catherine, et al.
Publicado: (2018)

Dicarbonyl Stress in Diabetic Vascular Disease
por: Stratmann, Bernd
Publicado: (2022)

Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle
por: Masania, Jinit, et al.
Publicado: (2022)

The Relationships Between Glycated Hemoglobin and Bone Turnover Markers in Patients with Type 2 Diabetes but No Diabetic Nephropathy
por: Zhao, Hang, et al.
Publicado: (2022)

Effect of Benfotiamine on Advanced Glycation Endproducts and Markers of Endothelial Dysfunction and Inflammation in Diabetic Nephropathy
por: Alkhalaf, Alaa, et al.
Publicado: (2012)

Neutrophils are immune cells preferentially targeted by retinoic acid in elderly subjects
por: Minet-Quinard, Régine, et al.
Publicado: (2010)

High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease
por: Thornalley, P. J., et al.
Publicado: (2007)

Reversal of Insulin Resistance in Overweight and Obese Subjects by trans-Resveratrol and Hesperetin Combination—Link to Dysglycemia, Blood Pressure, Dyslipidemia, and Low-Grade Inflammation
por: Rabbani, Naila, et al.
Publicado: (2021)

Association of α-Dicarbonyls and Advanced Glycation End Products with Insulin Resistance in Non-Diabetic Young Subjects: A Case-Control Study
por: Csongová, Melinda, et al.
Publicado: (2022)

Plasma Advanced Glycation End Products and Dicarbonyl Compounds Are Not Associated with Coronary Atherosclerosis in Athletes
por: BERGE, KRISTIAN, et al.
Publicado: (2023)

AGEomics Biomarkers and Machine Learning—Realizing the Potential of Protein Glycation in Clinical Diagnostics
por: Rabbani, Naila
Publicado: (2022)

Arginine-directed glycation and decreased HDL plasma concentration and functionality
por: Godfrey, L, et al.
Publicado: (2014)

Advanced glycation end products, oxidative stress and diabetic nephropathy
por: Yamagishi, Sho-ichi, et al.
Publicado: (2010)

Glycation-Associated Diabetic Nephropathy and the Role of Long Noncoding RNAs
por: Durge, Ankita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5aj5gnhcqluod86e4qu2a85eu7